Nenad Bartonicek
Overview
Explore the profile of Nenad Bartonicek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
2683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weeks A, Kriesner P, Bartonicek N, van Rooyen A, Cairns K, Ahrens C
Evol Lett
. 2025 Feb;
9(1):1-12.
PMID: 39906582
The evolutionary history of canids has been shown to be complex, with hybridization and domestication confounding our understanding of speciation among various canid lineages. The dingo is a recent canid...
2.
Quek C, Pratapa A, Bai X, Al-Eryani G, Pires da Silva I, Mayer A, et al.
Cell Rep
. 2024 Jun;
43(7):114392.
PMID: 38944836
Heterogeneous resistance to immunotherapy remains a major challenge in cancer treatment, often leading to disease progression and death. Using CITE-seq and matched 40-plex PhenoCycler tissue imaging, we performed longitudinal multimodal...
3.
Djajawi T, Pijpers L, Srivaths A, Chisanga D, Chan K, Hogg S, et al.
Cell Rep
. 2024 Feb;
43(3):113831.
PMID: 38401121
Cancer immunotherapies have demonstrated remarkable success; however, the majority of patients do not respond or develop resistance. Here, we conduct epigenetic gene-targeted CRISPR-Cas9 screens to identify epigenomic factors that limit...
4.
Pitesa N, Kurtovic M, Bartonicek N, Gkotsi D, conkas J, Petric T, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37239024
Background: Melanoma represents the deadliest skin cancer due to its cell plasticity which results in high metastatic potential and chemoresistance. Melanomas frequently develop resistance to targeted therapy; therefore, new combination...
5.
Baldwin L, Bartonicek N, Yang J, Wu S, Deng N, Roden D, et al.
Nat Commun
. 2022 Nov;
13(1):6539.
PMID: 36344500
Cancers evade the immune system through the process of cancer immunoediting. While immune checkpoint inhibitors are effective for reactivating tumour immunity in some cancer types, many other solid cancers, including...
6.
Kurtovic M, Pitesa N, Bartonicek N, Ozretic P, Musani V, conkas J, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139698
Background: Despite significant progress in therapy, melanoma still has a rising incidence worldwide, and novel treatment strategies are needed. Recently, researchers have recognized the involvement of the Hedgehog-GLI (HH-GLI) signaling...
7.
Bartonicek N, Rouet R, Warren J, Loetsch C, Rodriguez G, Walters S, et al.
Nature
. 2022 Aug;
608(7924):757-765.
PMID: 35948641
The notion that mobile units of nucleic acid known as transposable elements can operate as genomic controlling elements was put forward over six decades ago. However, it was not until...
8.
Wu S, Al-Eryani G, Roden D, Junankar S, Harvey K, Andersson A, et al.
Nat Genet
. 2021 Sep;
53(9):1334-1347.
PMID: 34493872
Breast cancers are complex cellular ecosystems where heterotypic interactions play central roles in disease progression and response to therapy. However, our knowledge of their cellular composition and organization is limited....
9.
Wu S, Roden D, Al-Eryani G, Bartonicek N, Harvey K, Cazet A, et al.
Genome Med
. 2021 May;
13(1):81.
PMID: 33971952
Background: High throughput single-cell RNA sequencing (scRNA-Seq) has emerged as a powerful tool for exploring cellular heterogeneity among complex human cancers. scRNA-Seq studies using fresh human surgical tissue are logistically...
10.
Youlten S, Kemp J, Logan J, Ghirardello E, Sergio C, Dack M, et al.
Nat Commun
. 2021 May;
12(1):2444.
PMID: 33953184
Osteocytes are master regulators of the skeleton. We mapped the transcriptome of osteocytes from different skeletal sites, across age and sexes in mice to reveal genes and molecular programs that...